Snapshot

  • HOME
  • BROWSE ARTICLES
  • Snapshot
Snapshot
EXAMINING THE THERAPEUTIC LANDSCAPE OF BETA-BLOCKERS IN PORTAL HYPERTENSION
Anna Brujats, Càndid Villanueva
Received February 24, 2024  Accepted March 4, 2024  
View: 405   Download: 17
1887
Immunopathogenesis of liver fibrosis in steatotic liver disease
Chaerin Woo, Won-Il Jeong
Clin Mol Hepatol. 2024;30(2):299-302.   Published online February 19, 2024
View: 703   Download: 42
Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
Received December 21, 2023  Accepted December 28, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0555    [Epub ahead of print]
View: 1150   Download: 49
1861
Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
Young Chang, Soung Won Jeong, Jae Young Jang
Clin Mol Hepatol. 2024;30(1):129-133.   Published online October 13, 2023
View: 1420   Download: 105
1843
The role of the hepatic autonomic nervous system
Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin
Clin Mol Hepatol. 2023;29(4):1052-1055.   Published online July 25, 2023
View: 1498   Download: 54
1834
HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
Soon Kyu Lee, Jung Hyun Kwon
Clin Mol Hepatol. 2023;29(3):825-827.   Published online May 31, 2023
View: 1987   Download: 87
1783
Systemic therapy in advanced hepatocellular carcinoma
Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
Clin Mol Hepatol. 2023;29(2):516-519.   Published online February 20, 2023
View: 3123   Download: 158  Web of Science: 3  Crossref: 3
1750
Epidemiology and updated management for autoimmune liver disease
Nae-Yun Heo, Haeryoung Kim
Clin Mol Hepatol. 2023;29(1):194-196.   Published online December 14, 2022
View: 3780   Download: 142  Web of Science: 2  Crossref: 4
1693
Microbiome and metabolomics in alcoholic liver disease
Raja Ganesan, Ki Tae Suk
Clin Mol Hepatol. 2022;28(3):580-582.   Published online July 1, 2022
View: 4182   Download: 149  Web of Science: 3  Crossref: 4
1689
Personalized medicine in nonalcoholic fatty liver disease
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):935-938.   Published online June 24, 2022
View: 3446   Download: 135  Web of Science: 4  Crossref: 4
1662
Acute on chronic liver failure in cirrhosis
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2022;28(2):273-275.   Published online February 14, 2022
View: 4931   Download: 216  Web of Science: 1  Crossref: 1
1650
Current status and outcome of liver transplantation in South Korea
Ho Joong Choi
Clin Mol Hepatol. 2022;28(1):117-119.   Published online December 7, 2021
View: 4866   Download: 87  Web of Science: 7  Crossref: 9
1635
History and future of hepatitis B virus control in South Korea
Do Young Kim
Clin Mol Hepatol. 2021;27(4):620-622.   Published online September 23, 2021
View: 6711   Download: 153  Web of Science: 8  Crossref: 8
1618
Hepatocellular carcinoma statistics in South Korea
Young Eun Chon, Soung Won Jeong, Dae Won Jun
Clin Mol Hepatol. 2021;27(3):512-514.   Published online June 21, 2021
View: 5633   Download: 170  Web of Science: 24  Crossref: 24

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 88
TOTAL : 1766908
Close layer